NCT00500578View on ClinicalTrials.gov

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

PHASE4CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Hematological Malignancies

Interventions

DRUG

Ribavirin

Arm 1 = 6 Grams Over 18 hours Every 24 Hours

DRUG

Ribavirin

Arm 2 = 2 Grams Over 3 Hours Every 8 Hours.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

ICN Pharmaceuticals

All Listed Sponsors

collaborator

ICN Pharmaceuticals

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER